about
How (and why) the immune system makes us sleep.Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease.The reciprocal link between sleep and immune responses.Sleep regulation: interactions among cytokines and classical neurotransmitters.Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicityChanges in sleep--waking cycle induced by lesions of medialis dorsalis thalamic nuclei in the cat.Thermoregulation as a non-unified system: A difficult to teach concept.Interleukin-1beta modulates state-dependent discharge activity of preoptic area and basal forebrain neurons: role in sleep regulation.Serotonergic activation stimulates the pituitary-adrenal axis and alters interleukin-1 mRNA expression in rat brain.Interleukin-1beta enhances non-rapid eye movement sleep when microinjected into the dorsal raphe nucleus and inhibits serotonergic neurons in vitro.Antagonism of corticotropin-releasing hormone alters serotonergic-induced changes in brain temperature, but not sleep, of rats.Selective blockade of different brain stem muscarinic receptor subtypes: effects on the sleep-wake cycle.Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model.Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials.Changes in the serotonergic system during the sleep-wake cycle: simultaneous polygraphic and voltammetric recordings in hypothalamus using a telemetry system.Effect of buspirone and its metabolite 1-(2-Pyrimydinyl)-piperazine on hippocampal serotoninergic system, studied in freely moving ratsFebrile and sleep responses to an immune challenge are affected by trait aggressiveness in rats
P50
Q33731135-F75B1ABA-87D8-45AA-9613-9A4DB9684D1CQ35448997-9AE54F7F-6A00-4573-89A0-80CEBC94EA3AQ38398369-AF1D4957-4161-47C3-8FD9-17D448FD5DBCQ40381279-7F37F295-3457-43BC-8E78-7EA0E96C6E7EQ40796560-652F35EB-E1DF-45F0-96D8-E3056CBDC6AFQ41437373-DC18E1FC-833C-4AF1-9A93-BC5690CC3A4FQ42315580-9D51737C-590E-4A75-8CAD-56398DE08CD9Q42464377-B944E283-09E1-476D-9577-52999988E0FFQ44533513-E11C5B35-C330-4E35-8FA0-7073FF985DEFQ44574074-E605C4E9-2D99-4E8D-8FFD-E242D14FAA83Q46580722-18398747-873D-49B4-AA39-C7EC04A7BE9BQ48175581-4A68C859-F9C2-4F8E-976F-45A1DD48BCE3Q48417286-B51CA39D-4AA4-4F29-81EE-61B51BA3A92CQ48456999-8AE5691E-1BE5-4EC7-97E2-36910CBA268FQ48856924-4E8EFB04-C827-4549-A11B-92EAF6E1F27FQ61389899-4430C43E-484A-43A7-8983-EA51DBEDEE04Q92891401-E298B38E-AFC7-48BE-A9F5-EBF1E43A7604
P50
description
researcher ORCID ID = 0000-0003-0753-004X
@en
wetenschapper
@nl
name
Luca Imeri
@ast
Luca Imeri
@en
Luca Imeri
@es
Luca Imeri
@nl
type
label
Luca Imeri
@ast
Luca Imeri
@en
Luca Imeri
@es
Luca Imeri
@nl
prefLabel
Luca Imeri
@ast
Luca Imeri
@en
Luca Imeri
@es
Luca Imeri
@nl
P106
P1153
7004642103
P31
P496
0000-0003-0753-004X